CD14 and Posterior Leukoencephalopathy Syndrome: Here, CD14++/CD16+ monocytes predicted diagnosis of PRES (OR 1.3 CI 1.1–7.0, p < 0.01, R = 0.22) indicating that monocytes might hold value for improving the diagnostic approach to PRES.